At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02566 JIUYUAN GENE
Market Closed 03-06 15:58:57
8.200
-0.040
-0.49%
High8.400
Low8.200
Vol34.00K
Open8.240
D1 Closing8.240
Amplitude2.43%
Mkt Cap1.98B
Tradable Cap869.20M
Total Shares242.00M
T/O282.96K
T/O Rate0.03%
Tradable Shares106.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
JIUYUAN GENE (02566) Reports February 2026 Share Repurchases and Updated Public Float
Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd, formerly Hangzhou Jiuyuan Gene Engineering Co Ltd, is a China-based company principally engaged in the research, development, manufacturing and commercialization of biopharmaceutical products and medical devices. The Company focuses on orthopedics, metabolic diseases, oncology and blood treatment. The Company's orthopedic products include Guyoudao bone repair materials. The Company's oncology products include Jilifen, Jijufen, Jiouting, Jifuwei, and Jitansu. The Company's blood products include Jipailin and Yinuojia. The Company's products are mainly used to treat diseases such as diabetes, multiple myeloma, thrombocytopenia, and neutropenia. The Company mainly operates its businesses in the domestic and overseas markets.